A211801, "BRCA-P: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, International Phase 3 Study to Determine the Preventive Effect of Denosumab on Breast Cancer in Women Carrying a BRCA1 Germline Mutation,"
Type of Study
University of Colorado Hospital
Marie Wood, MD
Protocol Number: 22-2040
More information available at ClinicalTrials.gov: NCT04711109
Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers